News

Valneva: Renowned Vaccinologist Dr. Stanley Plotkin to Present at R&D Investor Day in New York City on July 9th

Valneva SE (“Valneva” or “the Company”), a biotech company developing and commercializing vaccines for infectious diseases with major unmet medical…

Read more

How cells quickly activate innate immunity

Upon infection cells manage to quickly switch from normal operation to immune reaction in a matter of minutes. This innate immunity requires a…

Read more

SCARLETRED: Patents granted in Japan and Australia

IP Protection for Scarletred®Vision in the EU, USA, Japan and Australia.

Read more

Valneva Submits Delisting Application to the Vienna Stock Exchange

  • Annual general meeting on June 27, 2019 resolved on the delisting of Valneva’s ordinary shares from the Vienna Stock Exchange
  • Delisting shall be…
Read more

Valneva Initiates Second Phase 2 Study for its Lyme Disease Vaccine Candidate VLA15

Valneva SE (“Valneva” or “the Company”), a biotech company developing and commercializing vaccines for infectious diseases with major unmet needs,…

Read more

PhagoMed Biopharma GmbH successfully completed another financing round.

Investors provided further €1.5 million in equity investments to support phage therapy to tackle the antibiotics crisis.

Read more

Valneva Shareholders Approve all Resolutions Recommended by the Management Board at the Annual General Meeting

Valneva SE (“Valneva” or “the Company”), a biotech company developing and commercializing vaccines for infectious diseases with major unmet needs,…

Read more

bio.tools - a comprehensive database of life sciences software

A two-days workshop focused on practical use of bio.tools, a comprehensive registry of research software and databases led by the guest lecturer Radka…

Read more

Valneva Announces Mutual Agreement with GSK to End Strategic Alliance Agreement; Regains Control of R&D

Valneva SE (“Valneva” or “the Company”), a biotech company developing and commercializing vaccines for infectious diseases with major unmet needs,…

Read more

New tool for visualizing molecule properties developed at the Max Perutz Labs

Nucleic acids and proteins can be described on different structural levels, but all depend on the most basic - the primary structure. It describes the…

Read more

“I am excited by the idea that we discover the unknown about the most fundamental things in life.”

Originally from Turkey, Elif Karagöz’s scientific journey brought her to Germany to do her Master’s and to the Netherlands for her PhD at Utrecht…

Read more